Skip to main content

Closed

BMY: Bristol-Myers Squibb Company Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth-0.2% / yr

Operating margin28.3%

ROIC15.5%

Financially safe

Strong

Debt / equity1.93×

Interest coverage8.0×

Current ratio1.53×

Valuation

Unrated

P/E ratio14.4×

Dividend yield3.8%

Bristol-Myers Squibb Company

BMYNYSE·USD·Closed

Bristol-Myers Squibb Company

BMYNYSE·USD·Closed

$65.31

+0.69%

$65.31

+$0.45 (0.69%)

52W Range

98thpctl

Volume

0.85×avg

Mkt Cap

133.37BUSD

P/E

14.4TTM

Div Yield

3.84%ann

52W Range

98thpctl

Volume

0.85×avg

Market Cap

133.37BUSD

P/E Ratio

14.4TTM

Div Yield

3.84%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings